PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE

por Gkalea, V., Tseke, P., Pappas, T., Kotsiauti, A., Petrou, V., Psimenou, E., Matsouka, C.
Publicado 2022

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit

por Dimopoulos, M A, Roussou, M, Gavriatopoulou, M, Fotiou, D, Ziogas, D C, Migkou, M, Panagiotidis, I, Eleutherakis-Papaiakovou, E, Kanellias, N, Psimenou, E, Marinaki, S, Bacharaki, D, Mparmparoussi, D, Matsouka, C, Giannouli, S, Terpos, E, Kastritis, E
Publicado 2017

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib

por Kastritis, E, Gavriatopoulou, M, Roussou, M, Fotiou, D, Ziogas, D C, Migkou, M, Eleutherakis-Papaiakovou, E, Panagiotidis, I, Kanellias, N, Psimenou, E, Papadopoulou, E, Pamboucas, C, Manios, E, Gakiopoulou, H, Ntalianis, A, Tasidou, A, Giannouli, S, Terpos, E, Dimopoulos, M A
Publicado 2017